insights_auto
Why is ICLR down 2.94%?
Dive Deeperchevron_right
ICLR:NASDAQ
ICON PLC
$205.14
arrow_downward
-2.94%(-6.22) 1D
$205.00
arrow_downward
-0.07% (-0.14)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICLR...
Open
$206.00
High
$211.00
Low
$202.84
Mkt. cap
15.37B
Avg. vol.
1.14M
Volume
0.00
P/E ratio
83.83
52-wk high
$219.04
52-wk low
$66.57
EPS
$2.45
Beta
1.24
Shares outstanding
77.15M
No. of employees
40K
Open
$206.00
High
$211.00
Low
$202.84
Mkt. cap
15.37B
Avg. vol.
1.14M
Volume
0.00
P/E ratio
83.83
52-wk high
$219.04
52-wk low
$66.57
EPS
$2.45
Beta
1.24
Shares outstanding
77.15M
No. of employees
40K
News stories
From web sources and news partners
marketscreener.com
·
27 minutes ago
S&P 500 index fell sharply after Stockholm exchange close Monday
BigGo Finance
·
13 minutes ago
Nasdaq Vice Chairman Warns: Taiwan Stocks Climb to World's Fourth Largest, but 79% AI Exposure Tops the Globe
Quantisnow
·
50 minutes ago
Pershing Square USA, Ltd. Releases Third Quarter 2026 Portfolio Review
MarketWatch
·
8 hours ago
Nasdaq Inc. stock outperforms competitors on strong trading day
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress.
As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC